Globus Medical (GMED) PT Raised to $30 at BofA/Merrill Lynch Following Q4, Branch Deal
BofA/Merrill Lynch analyst Bob Hopkins reiterated a Buy rating and boosted his price target on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
